Clinical Trials Browser

Phase 1/2 × Neoplasm Metastasis × orteronel × Clear all

NCT00569153 2016-04-04

TAK-700

Phase 1/2 Completed

Neoplasm Metastasis, Prostatic Neoplasms

NCT02054793 2014-07-23

Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)

Phase 1/2 Withdrawn

Neoplasm Metastasis, Prostatic Neoplasms